Perfusion Practice Trends — 20-Year Dashboard
2006 (N=803) · 2011 (N=862) · 2026 Live (N=0) — Shackelford et al., MUSC
0
2026 Live
862
2011
803
2006
20+
Years Tracked
27
Core Questions

Showing % "Yes" for each question. 2006 data verified from raw SurveyMonkey export (N=803). 2026 updates live.

Heparin concentration monitoring during CPB

2006
40.6%
N=803
2011
39.9%
N=862
2026
—
pending
2006→2011: -0.7%

Arterial line filter

2006
99.1%
N=803
2011
98%
N=862
2026
—
pending
2006→2011: -1.1%

RAP/AAP autologous priming

2006
50.8%
N=803
2011
63%
N=862
2026
—
pending
2006→2011: +12.2%

Biocompatible circuit

2006
62.5%
N=803
2011
84.7%
N=862
2026
—
pending
2006→2011: +22.2%

AMICAR use

2006
70.9%
N=803
2011
79.6%
N=862
2026
—
pending
2006→2011: +8.7%

Vacuum Assisted Venous Drainage (VAVD)

2006
56.3%
N=803
2011
62.2%
N=862
2026
—
pending
2006→2011: +5.9%

3/8" venous line with VAVD

2006
16.1%
N=803
2011
41.6%
N=862
2026
—
pending
2006→2011: +25.5%

Terumo CDI / in-line blood gas monitor

2006
47.1%
N=803
2011
88.6%
N=862
2026
—
pending
2006→2011: +41.5%

Blood cardioplegia (majority of cases)

2006
94.8%
N=803
2011
84%
N=862
2026
—
pending
2006→2011: -10.8%

Substrate enhanced blood cardioplegia

2006
39.5%
N=803
2011
50.6%
N=862
2026
—
pending
2006→2011: +11.1%

Pulsatile perfusion during cross-clamp

2006
8.7%
N=803
2011
7.3%
N=862
2026
—
pending
2006→2011: -1.4%

Prescriptive oxygenator/tubing sizing

2006
16.1%
N=803
2011
33.8%
N=862
2026
—
pending
2006→2011: +17.7%

Bloodless surgery program

2006
16.1%
N=803
2011
21.1%
N=862
2026
—
pending
2006→2011: +5.0%

Intraoperative autologous donation pre-CPB

2006
20.7%
N=803
2011
25.1%
N=862
2026
—
pending
2006→2011: +4.4%

Divert shed blood to cell saver (not reservoir)

2006
50.6%
N=803
2011
57.7%
N=862
2026
—
pending
2006→2011: +7.1%

Platelet-Gel — cardiac procedures

2006
20%
N=803
2011
25.8%
N=862
2026
—
pending
2006→2011: +5.8%

Platelet-Gel — non-cardiac cases

2006
33.8%
N=803
2011
32%
N=862
2026
—
pending
2006→2011: -1.8%

Cell saver responsibility outside cardiac

2006
55.4%
N=803
2011
55.7%
N=862
2026
—
pending
2006→2011: +0.3%

IABP responsibility during insertion

2006
63.9%
N=803
2011
87%
N=862
2026
—
pending
2006→2011: +23.1%

Automated charting — current use

2006
13.6%
N=803
2011
20.2%
N=862
2026
—
pending
2006→2011: +6.6%

Automated charting — plan within 5 years

2006
55%
N=803
2011
69%
N=862
2026
—
pending
2006→2011: +14.0%

Cerebral oximetry (NIRS) — routine use

2006
26.5%
N=803
2011
37.7%
N=862
2026
—
pending
2006→2011: +11.2%

Mini circuit — plan within 5 years

2006
37.5%
N=803
2011
28.5%
N=862
2026
—
pending
2006→2011: -9.0%

Centrifugal pump retrograde check valve

2006
23.2%
N=803
2011
40.1%
N=862
2026
—
pending
2006→2011: +16.9%

Filter crystalloid portion of cardioplegia

2006
19.6%
N=803
2011
17.6%
N=862
2026
—
pending
2006→2011: -2.0%

Oncotic agent in prime (non-Mannitol)

2006
52.3%
N=803
2011
54.2%
N=862
2026
—
pending
2006→2011: +1.9%

Mannitol in prime

2006
90.2%
N=803
2011
82.8%
N=862
2026
—
pending
2006→2011: -7.4%

Filter crystalloid CP portion

2006
19.6%
N=803
2011
17.6%
N=862
2026
—
pending
2006→2011: -2.0%
Shackelford AG et al. · MUSC Cardiovascular Perfusion · 2004–2026 🖤💛